READ. SCROLL. LISTEN.

Original briefings. Zero spin.

Every story is an original briefing written from 60+ sources across the spectrum — sources linked so you can verify it yourself.

← Back to headlines

Morgan Stanley Flips Bullish on China Stocks, Targets Double-Digit Gains Through 2027

Morgan Stanley Flips Bullish on China Stocks, Targets Double-Digit Gains Through 2027
Morgan Stanley has done a 180 on Chinese equities — upgrading its outlook, raising price targets, and betting on AI-driven tech growth to sustain a rally that's already one of the world's best this year. Here's what Wall Street is saying, what the mainstream financial press is glossing over, and why American investors need to think hard before chasing this trade.

The Upgrade

Morgan Stanley has reversed course on China equities.

In February 2025, the firm upgraded Chinese stocks from "Underweight" to "Equal Weight," according to Yicai Global. It raised its year-end MSCI China target from 63 to 77 and bumped the Hang Seng target from 19,400 to 24,000.

By November 2025, Morgan Stanley issued the first 2026 outlook by any Wall Street bank on Chinese stocks, according to the South China Morning Post. New targets: MSCI China at 90 (up 3.4%), Hang Seng at 27,500 (up 3.5%), CSI 300 at 4,840 (up 4.6%).

Then came the longer-range call. Per CNBC, Morgan Stanley set 2Q 2027 price targets at 28,400 for the Hang Seng, 91 for MSCI China, 9,900 for the HSCEI, and 5,400 for the CSI 300 — implying upsides of 8%, 12%, 11%, and 11% respectively.

The shift occurred in less than six months.

What's Driving This

Morgan Stanley strategist Laura Wang pointed to three factors.

First: DeepSeek. The January 2025 release of DeepSeek-R1 — a cost-competitive large language model from Hangzhou-based DeepSeek — forced global investors to reassess China's AI capabilities. Wang said it directly sparked the Hang Seng Tech Index surge of 6.5% in a single day, per Yicai Global. The index was up 31% year-to-date at that point.

Second: Alibaba's earnings. The company's net profit more than tripled in Q4 2024, hitting CNY 48.9 billion ($6.7 billion), according to Yicai Global. Revenue rose 8% to CNY 280.2 billion. Cloud services — powered by AI demand — drove the gains. Alibaba's Hong Kong stock climbed 68% year-to-date.

Third: geopolitical shifts. Morgan Stanley flagged potential "symbolic deliverables" from a Trump-Xi meeting, including selected trade relaxations and resumed talks on fentanyl and climate, per CNBC.

Wall Street's Broader Repositioning

Goldman Sachs is projecting that widespread AI adoption could boost Chinese companies' earnings per share by 2.5% annually over the next decade, according to ecns.cn. Goldman believes improved growth prospects, combined with rising investor confidence, could increase the fair value of Chinese stocks by 15-20% — potentially pulling in over $200 billion in portfolio inflows.

Multiple Wall Street firms are repositioning on China simultaneously.

The Caveats in Morgan Stanley's Call

The financial press reporting on the upgrade has glossed over why Morgan Stanley was bearish in the first place. In November 2024, the firm downgraded Chinese equities specifically because of trade tensions and the ongoing real estate sector collapse, per Yicai Global. Those problems remain unresolved. China's property sector is still struggling. Deflation continues — Morgan Stanley's own November 2025 report noted that deflation would "linger" through next year.

Morgan Stanley also forecasts only low-single-digit gains for 2026. Laura Wang stated that "current market momentum will be sustained instead of breaking for significant new highs." That characterization differs from a broad bull market thesis.

And Morgan Stanley has reversed its China positioning twice in under six months — from bullish, to "Underweight" in November 2024, back to bullish in February 2025.

The Geopolitical Dimension

China's supply chain dominance in high-end power and green tech is real. Morgan Stanley cited the firm's positioning in the global energy transition as a structural advantage, per CNBC.

But the United States government is actively working to chip away at that dominance. Semiconductor export controls, CHIPS Act investments, tariffs — these policies target China's tech advantage directly. A Trump-Xi diplomatic meeting could reverse course.

China's tech localization push — particularly in AI, semiconductors, and biotech — stems from U.S. export restrictions. The two efforts are directly linked to an adversarial relationship.

For Individual Investors

Retail investors should approach Wall Street's China calls with caution.

This is a trade suited to institutional money with long time horizons, sophisticated hedging, and the ability to absorb geopolitical risk. The same banks making bullish calls have compliance departments monitoring every executive order.

Moderate index upside of 8-12% over two years can evaporate in a week if a Taiwan flashpoint, new sanctions, or collapsed trade talks materialize.

Wall Street gets paid to be optimistic. The two reversals in six months underscore that point.

Sources used for this briefing

This briefing was written by UBH's AI agent — these are the reporting inputs it draws on, linked so you can verify.

center-left
BloombergChina’s Profit Outlook to Improve Further, Morgan Stanley Says
center-left
CNBCMorgan Stanley boosts price targets for China indexes, sees upside through 2Q 2027
unknown
yicaiglobalMorgan Stanley Upgrades Outlook on China Stocks; Tech Sector Surges
unknown
ecns.cnMorgan Stanley upgrades stance on China stocks in significant shift
unknown
scmpMorgan Stanley predicts mild gains in China stocks in 2026 as blistering rally cools | South China Morning Post